128 related articles for article (PubMed ID: 28877654)
1. NUCKS nuclear elevated expression indicates progression and prognosis of ovarian cancer.
Shi C; Qin L; Gao H; Gu L; Yang C; Liu H; Liu T
Tumour Biol; 2017 Sep; 39(9):1010428317714631. PubMed ID: 28877654
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
3. Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.
Liu T; Tan S; Xu Y; Meng F; Yang C; Lou G
Am J Cancer Res; 2015; 5(12):3659-67. PubMed ID: 26885454
[TBL] [Abstract][Full Text] [Related]
4. Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer.
Soliman NA; Zineldeen DH; El-Khadrawy OH
Asian Pac J Cancer Prev; 2014; 15(2):837-45. PubMed ID: 24568505
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
6. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
[TBL] [Abstract][Full Text] [Related]
7. Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.
Yang M; Wang X; Zhao Q; Liu T; Yao G; Chen W; Li Z; Huang X; Zhang Y
Tumour Biol; 2014 Aug; 35(8):7505-12. PubMed ID: 24789428
[TBL] [Abstract][Full Text] [Related]
8. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
9. LAMP3 expression correlated with poor clinical outcome in human ovarian cancer.
Wang D; Cao X; Zhang Y; Liu Y; Yao C; Ge W; Xu Y
Tumour Biol; 2017 Mar; 39(3):1010428317695014. PubMed ID: 28349821
[TBL] [Abstract][Full Text] [Related]
10. High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.
Tan L; Sha L; Hou N; Zhang M; Ma Q; Shi C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31152111
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.
Wang L; Mao Y; Du G; He C; Han S
Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
18. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
[TBL] [Abstract][Full Text] [Related]
19. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
Zhang W; Hou T; Niu C; Song L; Zhang Y
PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
[TBL] [Abstract][Full Text] [Related]
20. Dynamic expression of the vertebrate-specific protein Nucks during rodent embryonic development.
Drosos Y; Kouloukoussa M; Ostvold AC; Havaki S; Katsantoni E; Marinos E; Aleporou-Marinou V
Gene Expr Patterns; 2014 Jan; 14(1):19-29. PubMed ID: 24140890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
